Filter
1416
Text search:
intellectual
property
Featured
Recommendations
172
New Publications
329
Language
Document type
No document type
494
Studies & Reports
318
Guidelines
274
Manuals
155
Strategic & Response Plan
96
Training Material
40
Fact sheets
27
Situation Updates
6
Resource Platforms
3
Infographics
3
Countries / Regions
Global
126
India
24
Africa
23
Ukraine
22
South–East Asia Region
22
Uganda
18
Kenya
18
Western and Central Europe
18
Ethiopia
16
Myanmar / Burma
12
East and Southern Africa
12
West and Central Africa
12
Asia
12
Ghana
11
Nigeria
10
Syria
10
South Africa
10
Eastern Europe and Central Asia
10
Liberia
9
Nepal
9
Sierra Leone
8
Zambia
8
Cambodia
8
Rwanda
8
Bangladesh
8
Malawi
8
Yemen
8
Middle East and North Africa
8
South Sudan
7
Indonesia
7
Lesotho
7
Western Pacific Region
7
Tanzania
6
Congo, Democratic Republic of
5
Zimbabwe
5
Somalia
5
Pakistan
5
Mozambique
5
Guinea
4
Haiti
4
Afghanistan
4
Sudan
4
Vietnam
4
Burkina Faso
3
Cameroon
3
Philippines
3
Jordan
3
Germany
3
Thailand
3
North Macedonia
3
Eastern Europe
3
Laos
3
Tajikistan
3
Russia
3
Iran
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Iraq
2
Lebanon
2
China
2
Peru
2
Colombia
2
Ecuador
2
Botswana
2
Angola
2
Latin America and the Carribbean
2
Palestine
2
Djibouti
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
Senegal
1
Mali
1
Morocco
1
USA
1
Turkey
1
Egypt
1
Chad
1
Papua New Guinea
1
Benin
1
Namibia
1
Eswatini/ Swaziland
1
Brazil
1
Serbia
1
Bolivia
1
Greece
1
Libya
1
Mexico
1
Sri Lanka
1
Chile
1
Paraguay
1
Venezuela
1
Albania
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Estonia
1
Lithuania
1
Uzbekistan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
270
Clinical Guidelines
197
Public Health
143
Women & Child Health
114
Key Resources
87
Capacity Building
47
Pharmacy & Technologies
37
Toolboxes
Mental Health
128
HIV
127
COVID-19
109
Disability
82
TB
79
Caregiver
71
Planetary Health
68
NTDs
58
AMR
57
Rapid Response
55
Global Health Education
45
NCDs
39
Pharmacy
38
Conflict
33
Refugee
18
Health Financing Toolbox
18
Ebola
15
Natural Hazards
11
Social Ethics
11
Specific Hazards
6
Polio
5
Cholera
3
Zika
3
Good primary care may lead to fewer avoidable hospitalizations, but unsafe primary care can cause avoidable illness and injury, leading to unnecessary hospitalizations, and in some cases, disability and even death.Implementing system changes and practices are crucial to improve safety at all levels
...
Guidelines
HIV drug resistance
July 2017
WHO clinical guidelines.
For the first time, WHO has published guidelines to help (primarily) front-line healthcare providers give high-quality, compassionate, and respectful care to children and adolescents (up to age 18) who have or may have experienced sexual abuse, including sexual assault or r
...
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as technical and programme staff at government institution
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...